Deserpidine

This classification denotes an antihypertensive agent with the molecular formula C32H38N2O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9016E3VB47, chemically known as 3-beta,20-alpha-yohimban-16-beta-carboxylic acid, 18-beta-hydroxy-17-alpha-methoxy-, methyl ester, 3,4,5-trimethoxybenzoate (ester) but generally known as deserpidine, which bears US NIH Compound Identifier 8550. European Medicines Agency schedules Deserpidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06992MIG. The term DESERPIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules deserpidine in its Anatomical Therapeutic Chemical (ATC) Classification. DESERPIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule deserpidine under HS 29399900 and SITC 54149. As of Q4 2014, DESERPIDINE remains the US FDA Preferred Term for this commodity. Deserpidine bears US NLM identifiers UMLS ID C0175158 and NCI Concept Code C61699. SMILES: O(C1C(C2C(CN3C(C2)c2[nH]c4c(c2CC3)cccc4)CC1OC(=O)c1cc(OC)c(OC)c(OC)c1)C(=O)OC)C.